AI could spot cancer in bones faster
NCT ID NCT07196995
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an artificial intelligence (AI) model designed to detect bone lesions on whole-body PET/CT scans. Researchers will enroll 180 adults with suspicious bone findings to see how well the AI can tell benign from malignant lesions, and predict tumor type, genetics, and prognosis. The goal is to improve diagnosis of bone metastases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI foundation model for PET/CT image analysis
- What this could lead to
- If successful, this AI tool could help doctors spot bone lesions more accurately and quickly, potentially improving cancer diagnosis and treatment planning.
- What could go wrong
- This is a validation study, not a treatment trial. The AI may not perform better than standard methods, and results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Preventive radiation may stop bone events before they start — a trial puts it to the test
- Can a new capsule ease bone metastasis pain without opioids?
- Hip muscle repair method may improve walking after bone cancer surgery
- New model aims to predict jaw bone disease before it strikes
- Could removing the primary tumor boost survival in stage IV breast cancer with Bone-Only spread?
- New 25-Minute bone scan could spot cancer faster with less radiation